Back

Glucose-independent effects of empagliflozin on gap junction and extracellular matrix remodeling in volume overload heart failure

9 May 2026 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: New insights from animal models of heart failure and cardiomyopathy Heart Failure Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Matus Sykora

Centre of Experimental Medicine, Slovak Academy of Sciences, Bratislava (Slovakia)

4 More presentations in this session

Presentation thumbnail
Pharmacological MALT1 inhibition ameliorates cardiac inflammation and dysfunction in experimental autoimmune myocarditis
Doctor A. Remes (Kiel, DE)
Abstract
Presentation thumbnail
Integrated multi-omics reveals epigenetic control of renal damage in HFpEF
Miss N. Atzemian (Zurich, CH)
Abstract
Presentation thumbnail
Involvement of connexin 43 in brown adipose tissue dysfunction in type 2 diabetes
Doctor T. Egan Benova (Bratislava, SK)
Abstract
Presentation thumbnail
The role of mitochondrial respiratory pathways using different cardioplegic solutions in immature rat hearts: a comparative study on moderate and prolonged ischemic periods
Mr D. Verikas (Kaunas, LT)
Abstract

Access the full session

Session thumbnail
New insights from animal models of heart failure and cardiomyopathy

The Event

Event poster

Heart Failure 2026

9 May - 12 May 2026
You may be interested in
thumbnail
Congress Session
Heart Failure 2025 highlights
thumbnail
Congress Session
Unspoken aetiologies of heart failure
thumbnail
Congress Session
Bridging gaps in heart failure care: primary care trends, exercise, kidney function, and global health perspectives

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources